经剑突下手术在前纵隔肿瘤治疗中的研究进展

Progress of subxiphoid surgery in the treatment of anterior mediastinal tumors

近年来微创技术的迅猛发展且随着微创理念的普及,胸腔镜手术得到了广泛应用,传统开胸手术因创伤大、并发症多逐渐被胸腔镜手术替代。经单侧、双侧肋间胸腔镜手术或经剑突下胸腔镜手术、达芬奇机器人手术等各种前纵隔肿瘤切除术式也在各大医疗中心相继开展,虽取得了较好的临床疗效,但尚无一个系统的手术疗效评价方法,以至微创前纵隔肿瘤切除术的手术入路和切除范围成为国内外的热议话题,而国内外经剑突下切口入路前纵隔肿瘤切除术尚未制定明确的手术规范。本文就经剑突下手术入路在前纵隔肿瘤治疗中的最新研究结果作一综述,以期为手术规范的指定提供参考。

In recent years, with the rapid development of minimally invasive technology and the popularization of minimally invasive concept, thoracoscopic surgery has been widely used. Compared with traditional thoracotomy, thoracoscopic surgery has been gradually replaced by thoracoscopic surgery due to large trauma and more complications. Unilateral and bilateral thoracoscopic surgery, subxiphoid thoracoscopic surgery, Da Vinci robotic surgery and other surgical procedures for anterior mediastinal tumor resection have also been carried out in various major medical centers. Although good clinical efficacy has been achieved, there is no systematic evaluation method for surgical efficacy. As a result, the surgical approach and resection scope of minimally invasive anterior mediastinal tumor resection have become a hot topic at home and abroad. However, there is no clear domestic and foreign surgical standard for anterior mediastinal tumor resection through subxiphoid incision. Based on this, this article discusses the research progress of subxiphoid surgical approach in the treatment of anterior mediastinal tumors.